MEMPHIS, Tenn., Nov. 10, 2011 /PRNewswire-USNewswire/ -- ACORN Research has expanded its research footprint to support advances in personalized medicine and translational research, by offering high-quality biospecimens coupled with unprecedented premium data to industry and academic research through its partnership with AdeptBio, LLC (http://www.adeptbio.com).
ACORN Research is able to provide CRO services as needed to facilitate prospective collections of biospecimens from targeted study populations. "Development of new targeted therapies and companion diagnostics rely on availability of tissues, and increasingly biofluids, linked to deep clinical data. Banked samples are less able to meet this need, and therefore our model is aimed at optimizing prospective collections," reports Dr. Lee Schwartzberg, president of ACORN Research.
Leif Honda, AdeptBio, LLC, CEO, adds, "Researcher's needs are changing as biomarkers and companion diagnostics emerge along with new regulatory requirements. AdeptBio's relationship with ACORN Research presents an end-to-end answer to meet those needs. We are delighted to be entering into this partnership with ACORN Research as a CRO with an excellent history of success with its clients and rapport with their oncology network."
ACORN Research and AdeptBio are committed to helping the research community make significant advancements in the prevention, diagnosis, and treatment of cancer, through the provision of relevant, leading edge biospecimens and associated data.
About ACORN Research, LLC
ACORN Research, LLC is a multi-faceted research organization that combines a network of committed oncology research sites supported by centralized research processes; a bioinformatics platform that joins EMR data with ePRO data to support health outcomes research and clinical trial efficiencies; and a contract research organization focused exclusively on oncology. We offer high quality biospecimens and biofluids using unmatched sophistication in donor services.
About AdeptBio, LLC
AdeptBio, LLC is a human biospecimen contract procurement organization formed through a partnership between experts in specimen procurement, contract research, biomarker discovery, diagnostics and therapeutic R&D. AdeptBio addresses the dramatically underserved needs of pharmaceutical and diagnostic R&D companies by overcoming the challenges of supply constraints, quality, consistency, and sample diversification. The company offers complete transparency in acquisition and accrual rates across a robust network providing thorough patient data and sample characterization, and the option for longitudinal access to information. The goal of the company is to meet increasing regulatory demands by providing the most complete medical information available to researchers.
To learn more, visit http://www.acornresearch.net.
|SOURCE ACORN Research|
Copyright©2010 PR Newswire.
All rights reserved